Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Hematologic Diseases
×
Rituximab
×
90 days
×
Clear all
Filters
3
NCT04965493
2026-01-29
BRUIN CLL-322
Eli Lilly and Company
Phase 3
Active not recruiting
600 enrolled
NCT05023980
2026-01-22
BRUIN CLL-313
Eli Lilly and Company
Phase 3
Active not recruiting
309 enrolled